These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4068230)

  • 1. [Progress in the endocrine therapy of breast cancer].
    Nomura Y
    Gan No Rinsho; 1985 May; Suppl():114-5. PubMed ID: 4068230
    [No Abstract]   [Full Text] [Related]  

  • 2. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
    Stelzer P; Staab HJ; Kömpf J
    Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current aspects of hormone therapy in carcinoma of the breast].
    Sesti F; Piccione E
    Minerva Ginecol; 1987 Nov; 39(11):765-71. PubMed ID: 3328113
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid receptors in breast cancer.
    Drafta D
    Endocrinologie; 1980; 18(2):117-21. PubMed ID: 7384734
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
    Wittliff JL; Day TG; Dean WL; Allegra JC
    Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen.
    Kopp A; Jonat W; Schmahl M; Knabbe C
    Cancer Res; 1995 Oct; 55(20):4512-5. PubMed ID: 7553618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma].
    Prodi G; Lollini PL; Nicoletti G
    Minerva Med; 1984 Feb; 75(6):219-21. PubMed ID: 6709205
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing endocrine therapy for breast cancer.
    Winer EP
    J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of endocrine therapy for advanced breast cancer.
    Bland KI
    Ann Surg Oncol; 1999 Dec; 6(8 Suppl):4S-7S. PubMed ID: 10619452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of receptor data in clinical oncology].
    Amadori D; Frassineti L
    Pathologica; 1987; 79(1059-1060):187-9. PubMed ID: 3327043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Receptor correlation between histochemical and biochemical methods in advanced breast carcinoma].
    Simone G; Paradiso A; Labriola A; Petroni S; Tommasi S; Schittulli F
    Pathologica; 1987; 79(1059-1060):113-8. PubMed ID: 3441401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.
    Lundgren S; Søreide JA; Lea OA
    Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [7 years' experience in the determination of hormone receptors in cancer of the breast. Current status and prospectives for the surgeon].
    Pietrarota P; Battistoni MG; Caprioli F
    Pathologica; 1987; 79(1059-1060):105-8. PubMed ID: 3441400
    [No Abstract]   [Full Text] [Related]  

  • 20. [The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
    Gitsch E; Salzer H
    Wien Klin Wochenschr; 1983 May; 95(11):385-8. PubMed ID: 6310902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.